Wu-Chou Su

Personal profile

Education

1983 MD, College of Medicine, National Taiwan University

Research Interests

Cell Signaling Transduction
Nanomedicine
Oncology
Clinical Trial

Experience

2004/08~now Professor, Department of Internal Medicine, College of Medicine, National Cheng Kung University
2017/08~now Director, Department of Internal Medicine, National Cheng Kung University Hospital
2004/07~now Chief, Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital
1990/08~now Attending Physician, National Cheng Kung University Hospital
2011/10~2017/07 Director, Cancer Center, National Cheng Kung University Hospital
2006/01~2011/09 Director, Clinical Trial Center, National Cheng Kung University Hospital

Fingerprint Dive into the research topics where Wu-Chou Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

25 Similar Profiles

Lung Neoplasms Medicine & Life Sciences

Non-Small Cell Lung Carcinoma Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Epidermal Growth Factor Receptor Medicine & Life Sciences

Mutation Medicine & Life Sciences

Drug Therapy Medicine & Life Sciences

Smoking Medicine & Life Sciences

Taiwan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

研究介質素-6特殊醣化型調控肺癌幹細胞功能及誘發肺癌轉移模式之機轉

Su, W.

19-08-01 → 20-07-31

Project: Research project

研究介質素-6在肺癌細胞中之醣化型及其生物功能

Su, W.

17-08-01 → 18-07-31

Project: Research project

研究介質素-6在肺癌細胞中之醣化型及其生物功能

Su, W.

16-08-01 → 17-07-31

Project: Research project

研究介質素-6在肺癌細胞中之醣化型及其生物功能

Su, W.

15-08-01 → 16-07-31

Project: Research project

磁性合金奈米粒子之診療一體平台臨床與產業開發

Su, W.

14-01-01 → 14-12-31

Project: Research project

Research Output 1987 2019

11963 Citations
48 h-Index
204 Article
4 Letter
4 Patent
3 Conference contribution
2 More
- 1 Comment/debate
- 1 Review article

A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

Lin, C. C., Arkenau, H. T., Lu, S., Sachdev, J., de Castro Carpeño, J., Mita, M., Dziadziuszko, R., Su, W. C., Bobilev, D., Hughes, L., Chan, J., Zhang, Z. Y. & Weiss, G. J., 2019 Jul 16, In : British Journal of Cancer. 121, 2, p. 131-138 8 p.

Research output: Contribution to journal › Article

Open Access

Lymphoma

Neoplasms

Safety

Non-Small Cell Lung Carcinoma

Maximum Tolerated Dose

Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLC

Lin, C. Y., Chang, C. C., Su, P. L., Lin, C. C., Tseng, Y. L., Su, W. C., Yen, Y. T. & Patel, G., 2019 Aug 1, In : Medicine (United States). 98, 33, e16766.

Research output: Contribution to journal › Article

Open Access

Neuroimaging

Non-Small Cell Lung Carcinoma

Neoplasm Metastasis

Disease-Free Survival

Epidermal Growth Factor Receptor

1 Citation (Scopus)

Dynamic Changes of Health Utility in Lung Cancer Patients Receiving Different Treatments: A 7-Year Follow-up

Yang, S. C., Kuo, C. W., Lai, W. W., Lin, C. C., Su, W. C., Chang, S. M. & Wang, J. D., 2019 Nov, In : Journal of Thoracic Oncology. 14, 11, p. 1892-1900 9 p.

Research output: Contribution to journal › Article

Open Access

Lung Neoplasms

Health

Quality of Life

Drug Therapy

Therapeutics

Erratum: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy (Oncotarget (2015) 6 (13671–13687) DOI: 10.18632/oncotarget.3701)

Hsu, T. I., Chen, Y. J., Hung, C. Y., Wang, Y. C., Lin, S. J., Su, W. C., Lai, M. D., Kim, S. Y., Wang, Q., Qian, K., Goto, M., Zhao, Y., Kashiwada, Y., Lee, K. H., Chang, W. C. & Hung, J. J., 2019 Jan 1, In : Oncotarget. 10, 60, p. 6536-6537 2 p.

Research output: Contribution to journal › Comment/debate

Lung Neoplasms

Growth

Neoplasms

betulinic acid